The colon and rectum are parts of the gut (gastrointestinal tract), which starts at the mouth and ends at the anus. When we eat or drink, the food and liquid travel down the esophagus into the stomach (which churns up the food) and then passes it into the small bowel or small intestine (several meters long and used for digestion and absorption of food). Undigested food, water, and waste products are then passed into the large bowel or large intestine, which is about 150 cm long, and its main part is called the colon. The colon is further split into four sections: The ascending, transverse, descending, and sigmoid colon. Some water and salts are absorbed into the body from the colon. The last part of the colon is called the rectum, which is about 15 cm long. The rectum stores stools (feces) before they are passed out from the anus. Colorectal cancer (also known as colon cancer, rectum cancer or bowel cancer) is the development of cancer in the colon or rectum. It is also called colorectal cancer or cancer of the large intestine. In contrast, cancer of the small intestine is rare. Bowel cancer can affect 
INTRODUCTION
any part of the colon or rectum. However, it commonly develops in the lower part of the descending colon, the sigmoid colon, or rectum. Bowel cancer usually develops from a small fleshy growth (polyp) which has formed on the lining of the colon or rectum. Sometimes, bowel cancer begins from a cell within the lining of the colon or rectum which becomes cancerous. [1] Several types of cancer can start in the colon or rectum: (i) Adenocarcinomas, which start in cells that form glands that make mucus to lubricate the inside of the colon and rectum. More than 95% of colorectal cancers are considered as adenocarcinomas, other comparatively less common types of tumors may also start in the colon and rectum, which include carcinoid tumors, gastrointestinal stromal, lymphomas tumors, and sarcomas. [2] Signs and symptoms of the colorectal cancer may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time. Risk factors for colorectal cancer include lifestyle, older age, and inherited genetic disorders that only occur in a small fraction of the population. Other risk factors include diet, smoking, alcohol, lack of physical activity, family history of colon cancer and colon polyps, presence of colon polyps, race, exposure to radiation, and even other diseases such as diabetes and obesity. A diet high in red, processed meat, while low in fiber increases the risk of colorectal cancer. Other diseases such as inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, can increase the risk of colorectal cancer. Some of the inherited conditions that can cause colorectal cancer include: Familial adenomatous polyposis and heredity nonpolyposis colon cancer; however, these represent <5% of cases. It typically starts as a benign tumor often in the form of a polyp, which over time becomes cancerous. [3] The colorectal cancer is the third and second most common cancer with estimated 1,361,000 cases in 2012, of which 746,000 occur in men and 614,000 cases in women. Of 746,000 cases in men (399,000 cases are from developed regions and 347,000 cases from less developed regions) and 614,000 cases in women (338,000 cases are from developed regions and 276,000 cases from less developed regions) in 2012. Among three major economies, the estimated cases were 147,000 in China, 69,000 cases in USA and 37,000 cases in India during 2012. The colorectal cancer incidence varies across different geographical regions. The highest estimated incidence rates was in Australia/New Zealand (age-standardized rates [ASR] of 44.8 and 32.2/100,000 in men and women, respectively) and the lowest in Western Africa (ASR of 4.5 and 3.8/10,000). There are an estimated 694,000 deaths (374,000 in men and 320,000 in women) because of colorectal cancer in 2012. Of the 374,000 deaths in men, 175,000 occur in more developed regions and 198,000 in less developed regions. Similarly, out of 320,000 deaths in women, 158,000 occur in more developed regions land 16,300 in less developed regions. Among three major economies, the estimated deaths were 253,000 in China, 134, cases in USA and 64,000 cases in India in 2012. The colorectal cancer deaths vary across different geographical regions. The highest estimated mortality rates in both sexes in Central and Eastern Europe (ASR of 20.3 and 11.7/100,000 for men and women, respectively) and the lowest in Western Africa (ASR of 3.5 and 3.0/10,000, respectively). [4] 
Literature review
In the past, there is no specific study on the scientometric analysis of colorectal cancer research, both at global and national level. However, only a few studies have been undertaken in the past on the assessment of contribution and impact of Indian cancer literature. Among such studies, Patra and Bhattacharya [5] analyzed growth of world and Indian oncology research during 1987-2003, including identification of most active Indian institutions, application of Bradford's law of scattering for identifying core journals and Lotka's law for author productivity in Indian cancer literature. Lewison and Roe [6] examined Indian cancer research output from 1990 to 2010, with focus on its publication growth, citation impact, international collaborative publications share, publication output by geographical areas, type of research, cancer site or manifestation and sources of funding. Indian research by cancer site correlated positively with the relative disease burden. Basu et al. [7] examined the contribution of Canada and USA settled (NRIs) Indian origin scholars in the field of cancer during: 1988-1990, 1998-2000, and 2008-2010 . Several authors such as Gupta and Bala, Gupta et al., Gupta et al. examined Indian publications output in bone marrow research, [8] oral cancer, [9] cervical cancer, [10] lymphoma cancer, [11] and prostate cancer. [12] These studies examined the literature growth, citation impact and global share, distribution of publications by sub-fields, type of research, cancer site, treatment methods and population age groups, contribution by type of Indian organizations and geographical distribution, contribution and citation impact of top organizations and authors and pattern of communication.
OBJECTIVES
The study makes a bibliometric assessment of Indian research in colorectal cancer during 2005-2014, based on publications output, as indexed in Scopus database. In particular, the study focuses on the following objectives:
• To study the growth of world and Indian research output and its distribution by type of publication • To study the citation pattern of the Indian research output • To study the global publication share and citation impact of top 15 most productive countries • To study the international collaboration share of Indian publication to identify the leading collaborative partners and their share in India's output • To study the distribution of Indian research output and their citation impact by broad subject areas • To study the distribution of Indian colorectal cancer output by treatment methods and their distribution by geographical areas • To study the publication productivity and citation impact of most productive 20 Indian institutions and authors; and • To study the medium of communication and the characteristics of high cited papers.
METHODOLOGY
The study covered publication data of the world and of 15 most productive countries in colorectal cancer as indexed in Scopus database (http://www.scopus.com) for 10 years during 2005-2014. The keyword "colon," "rectal," "bowel" or "colorectal" and "cancer or neoplasm or carcinoma" were used in "title, abstract and keyword" tag and restricting it to the period 2005-2014 in "date range tag" was used for searching the global publication data and this become the main search string. When the main search string with restricted to 15 most productive countries in "country tag," as shown below, the publication data on most productive countries, including India were obtained. When the main search string is further restricted to "subject area tag," "country tag," "source title tag," and "affiliation tag," we got information on distribution of publications by subject, collaborating countries, organization-wise, author-wise and journal-wise, etc., For citation data, the 3 years, Table 2 ].
Global publication share and citation impact of top 15 most productive countries
The global research output in colorectal cancer originated in 165 countries during 2005-2014, of which 110 countries produced 1-100 publications, 27 countries from 101 to 1000 publications, 16 countries from 1001 to 4000 publications, 5 countries from 4001 to 6000 publications, 1 country from 6001 to 8000 publications, 1 country from 8001 to 10,000 publications and 5 countries above 10,000 publications during 2005-2014. 
International collaboration

Distribution of publications by type of cancer
Among the different types of colorectal cancer publications, the largest publication share (12.49%) was registered by adenocarcinoma, followed by melanoma (7.86%), lymphomas (7.73%), squamous cell carcinoma (5.16%), sarcomas (3.48%), stromal tumors (1.97%), and carcinoid tumor (0.76%) during 2005-2014. The publication share has increased by 0.57% in squamous cell carcinoma, 0.43% in stromal tumors 0.19% in adenocarcinoma and 0.06% in carcinoid tumors, as against decrease in 1.31% in lymphomas, 0.47% in melanoma, and 0.44% in sarcomas [ Table 6 ]. 
Distribution of publications by geographical areas
Among India states and union territories contributing to colorectal cancer research during 2005-2014, the largest publication share (14.69%) came from Maharashtra, followed by Delhi (13.74%), Tamil Nadu (12.23%), Karnataka (7.89%), Uttar Pradesh (7.20%), A. Kamal (11) It is concluded that colorectal cancer is both highly preventable and can be highly curable when detected early, and it can be detected at a low cost. Governments can launch public awareness initiatives, create screening programs to detect cancer in eligible population, or offer treatment programs to aid residents. The governments can also build partnerships with the private sector and nonprofits to maximize resources to fund initiatives, keep awareness high, and increase colorectal cancer screening rates. It is suggested that government should develop a systematic screening programs for detection and diagnosis of colorectal cancer to be followed by the evolution of suitable management strategy and more effective treatment options for treatment of colorectal cancer. 
Medium of communication
